Anti-BAT1/ SLC7A9/ CSNU3 monoclonal antibody
Anti-BAT1/ SLC7A9/ CSNU3 antibody for FACS & in-vivo assay
Go to SLC7A9/SLC7A9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP1668-Ab-1/ GM-Tg-hg-MP1668-Ab-2 | Anti-Human SLC7A9 monoclonal antibody | Human |
GM-Tg-rg-MP1668-Ab-1/ GM-Tg-rg-MP1668-Ab-2 | Anti-Rat SLC7A9 monoclonal antibody | Rat |
GM-Tg-mg-MP1668-Ab-1/ GM-Tg-mg-MP1668-Ab-2 | Anti-Mouse SLC7A9 monoclonal antibody | Mouse |
GM-Tg-cynog-MP1668-Ab-1/ GM-Tg-cynog-MP1668-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLC7A9 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP1668-Ab-1/ GM-Tg-felg-MP1668-Ab-2 | Anti-Feline SLC7A9 monoclonal antibody | Feline |
GM-Tg-cang-MP1668-Ab-1/ GM-Tg-cang-MP1668-Ab-2 | Anti-Canine SLC7A9 monoclonal antibody | Canine |
GM-Tg-bovg-MP1668-Ab-1/ GM-Tg-bovg-MP1668-Ab-2 | Anti-Bovine SLC7A9 monoclonal antibody | Bovine |
GM-Tg-equg-MP1668-Ab-1/ GM-Tg-equg-MP1668-Ab-2 | Anti-Equine SLC7A9 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP1668-Ab-1/ GM-Tg-hg-MP1668-Ab-2; GM-Tg-rg-MP1668-Ab-1/ GM-Tg-rg-MP1668-Ab-2; GM-Tg-mg-MP1668-Ab-1/ GM-Tg-mg-MP1668-Ab-2; GM-Tg-cynog-MP1668-Ab-1/ GM-Tg-cynog-MP1668-Ab-2; GM-Tg-felg-MP1668-Ab-1/ GM-Tg-felg-MP1668-Ab-2; GM-Tg-cang-MP1668-Ab-1/ GM-Tg-cang-MP1668-Ab-2; GM-Tg-bovg-MP1668-Ab-1/ GM-Tg-bovg-MP1668-Ab-2; GM-Tg-equg-MP1668-Ab-1/ GM-Tg-equg-MP1668-Ab-2 |
Products Name | Anti-SLC7A9 monoclonal antibody |
Format | mab |
Target Name | SLC7A9 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-SLC7A9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species BAT1/ SLC7A9/ CSNU3 VLP (virus-like particle) (Products Developing) |
Target information
Target ID | GM-MP1668 |
Target Name | SLC7A9 |
Gene ID | 11136,30962,116726,703081,484601,101092316,508174,100056073 |
Gene Symbol and Synonyms | BAT1,CSNU3,SLC7A9 |
Uniprot Accession | P82251,P82252 |
Uniprot Entry Name | BAT1_HUMAN,BAT1_RAT |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000021488 |
Target Classification | N/A |
The target: SLC7A9, gene name: SLC7A9, also named as BAT1, CSNU3. This gene encodes a protein that belongs to a family of light subunits of amino acid transporters. This protein plays a role in the high-affinity and sodium-independent transport of cystine and neutral and dibasic amino acids, and appears to function in the reabsorption of cystine in the kidney tubule. Mutations in this gene cause non-type I cystinuria, a disease that leads to cystine stones in the urinary system due to impaired transport of cystine and dibasic amino acids. Alternate transcript variants, which encode the same protein, have been found for this gene. [provided by RefSeq, Jul 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.